TORRENT PHARMACEUTICALS
Back to Income Statement
|
TORRENT PHARMACEUTICALS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹2,163 Cr | ₹1,911 Cr | ₹1,656 Cr | ₹1,245 Cr | ₹777 Cr |
What is the latest Consolidated Net Profit of TORRENT PHARMACEUTICALS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹2,163 Cr |
| Mar2025 | ₹1,911 Cr |
| Mar2024 | ₹1,656 Cr |
| Mar2023 | ₹1,245 Cr |
| Mar2022 | ₹777 Cr |
How is Consolidated Net Profit of TORRENT PHARMACEUTICALS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,163 Cr | 13.19 | |
| Mar2025 | ₹1,911 Cr | 15.39 | |
| Mar2024 | ₹1,656 Cr | 33.02 | |
| Mar2023 | ₹1,245 Cr | 60.22 | |
| Mar2022 | ₹777 Cr | - | |
Compare Consolidated Net Profit of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹149,799.5 Cr | -1.8% | -0.1% | 36.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,794.0 Cr | 1.7% | -2.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹178,956.0 Cr | 2% | -2.2% | 1.5% | Stock Analytics | |
| CIPLA | ₹109,370.0 Cr | -2% | -3.3% | -9.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,133.0 Cr | -0.6% | -3.8% | -6.9% | Stock Analytics | |
| MANKIND PHARMA | ₹99,835.6 Cr | 1.5% | -6.4% | 1% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | -1.8% |
-0.1% |
36.7% |
| SENSEX | 1.7% |
2.1% |
-6% |
You may also like the below Video Courses